Clinical Trial Update: A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 completed trial comparing pegfilgrastim and filgrastim as supportive therapy in breast cancer patients receiving chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Febrile Neutropenia
• Neutropenia

Drugs mentioned

• Filgrastim (filgrastim)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Breast Cancer, Neutropenia | Phase 3 | Status: COMPLETED